Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults von Thompson, Allison, Lamberth, Erik, Severs, Joseph, Scully, Ingrid, Tarabar, Sanela, Ginis, John, Jansen, Kathrin U, Gruber, William C, Scott, Daniel A, Watson, Wendy

Volltext

Evaluation of a Janus kinase 1 inhibitor, PF‐04965842, in healthy subjects: A phase 1, randomized, placebo‐controlled, dose‐escalation study von Peeva, Elena, Hodge, Martin R., Kieras, Elizabeth, Vazquez, Michael L., Goteti, Kosalaram, Tarabar, Sanela G., Alvey, Christine W., Banfield, Christopher

Volltext

Safety, Pharmacokinetic, and Pharmacodynamic Evaluation After Single and Multiple Ascending Doses of a Novel Selective Androgen Receptor Modulator in Healthy Subjects von Bhattacharya, Indranil, PhD, Tarabar, Sanela, MD, MPH, Liang, Yali, MS, Pradhan, Vivek, MS, Owens, Jane, PhD, Oemar, Barry, MD

Volltext

Phase I Pharmacokinetic Study of Fixed-Dose Combinations of Ibuprofen and Acetaminophen in Healthy Adult and Adolescent Populations von Tarabar, Sanela, Kelsh, Debra, Vince, Bradley, Leyva, Rina, Song, Dongweon, Matschke, Kyle, Kellstein, David E., Meeves, Suzanne, Cruz-Rivera, Mario

Volltext

Efficacy and safety of topical brepocitinib for the treatment of mild‐to‐moderate atopic dermatitis: a phase IIb, randomized, double‐blind, vehicle‐controlled, dose‐ranging and par... von Landis, Megan N., Arya, Mark, Smith, Stacy, Draelos, Zoe, Usdan, Lisa, Tarabar, Sanela, Pradhan, Vivek, Aggarwal, Sudeepta, Banfield, Christopher, Peeva, Elena, Vincent, Michael S., Sikirica, Vanja, Xenakis, Jason, Beebe, Jean S.

Volltext

Oral tyrosine kinase 2 inhibitor PF-06826647 demonstrates efficacy and an acceptable safety profile in participants with moderate-to-severe plaque psoriasis in a phase 2b, randomiz... von Tehlirian, Christopher, Singh, Ravi Shankar P., Pradhan, Vivek, Roberts, Erika S., Tarabar, Sanela, Peeva, Elena, Vincent, Michael S., Gale, Jeremy D.

Volltext

Efficacy and Safety of PF-07038124 in Patients With Atopic Dermatitis and Plaque Psoriasis: A Randomized Clinical Trial von Eichenfield, Lawrence F, Tarabar, Sanela, Forman, Seth, García-Bello, Alfonso, Feng, Gang, Fetterly, Gerald, Mahling, Ping, Peeva, Elena, Vincent, Michael S, Chandra, Deepa E

Volltext

Inherited erythromelalgia due to mutations in SCN9A: natural history, clinical phenotype and somatosensory profile von McDonnell, Aoibhinn, Schulman, Betsy, Ali, Zahid, Dib-Hajj, Sulayman D, Brock, Fiona, Cobain, Sonia, Mainka, Tina, Vollert, Jan, Tarabar, Sanela, Waxman, Stephen G

Volltext

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Liver‐Targeting Acetyl‐CoA Carboxylase Inhibitor (PF‐05221304): A Three‐Part Randomized Phase 1 Study von Bergman, Arthur, Carvajal‐Gonzalez, Santos, Tarabar, Sanela, Saxena, Aditi R., Esler, William P., Amin, Neeta B.

Volltext

Safety, Tolerability, and Pharmacokinetics of PF‐06823859, an Anti–Interferon β Monoclonal Antibody: A Randomized, Phase I, Single‐ and Multiple‐Ascending‐Dose Study von Neelakantan, Srividya, Oemar, Barry, Johnson, Kristen, Rath, Natalie, Salganik, Mikhail, Berman, Gabe, Pelletier, Kathleen, Cox, Lori, Page, Karen, Messing, Dean, Tarabar, Sanela

Volltext

First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18 F-PF-05270430 von Naganawa, Mika, Waterhouse, Rikki N., Nabulsi, Nabeel, Lin, Shu-Fei, Labaree, David, Ropchan, Jim, Tarabar, Sanela, DeMartinis, Nicholas, Ogden, Adam, Banerjee, Anindita, Huang, Yiyun, Carson, Richard E.

Volltext

First-in-Human Assessment of the Novel PDE2A PET Radiotracer ^sup 18^F-PF-05270430 von Naganawa, Mika, Waterhouse, Rikki N, Nabulsi, Nabeel, Lin, Shu-Fei, Labaree, David, Ropchan, Jim, Tarabar, Sanela, DeMartinis, Nicholas, Ogden, Adam, Banerjee, Anindita, Huang, Yiyun, Carson, Richard E

Volltext

First-in-Human Assessment of the Novel PDE2A PET Radiotracer super( 18)F-PF-05270430 von Naganawa, Mika, Waterhouse, Rikki N, Nabulsi, Nabeel, Lin, Shu-Fei, Labaree, David, Ropchan, Jim, Tarabar, Sanela, DeMartinis, Nicholas, Ogden, Adam, Banerjee, Anindita, Huang, Yiyun, Carson, Richard E

Volltext

First-in-Human Assessment of the Novel PDE2A PET Radiotracer 18F-PF-05270430 von Naganawa, Mika, Waterhouse, Rikki N, Nabulsi, Nabeel, Lin, Shu-Fei, Labaree, David, Ropchan, Jim, Tarabar, Sanela, DeMartinis, Nicholas, Ogden, Adam, Banerjee, Anindita, Huang, Yiyun, Carson, Richard E

Volltext

Bioequivalence of Alprazolam Sublingual Tablet Formulation and Alprazolam Immediate Release Tablet in Healthy Volunteers von Damle, Bharat

Volltext